News
Bitcoin Miners Dominate the List. Summit Therapeutics Inc. (NASDAQ:SMMT) is one of Wednesday’s top performers. Summit ...
2h
Zacks Investment Research on MSNJ&J Expects Oncology Sales of USD 50B by 2030: Can It Achieve the Goal?Johnson & Johnson JNJ, on its second-quarter conference call, stated that it expects its oncology sales to reach $50 billion ...
4h
MyNewsLA.com on MSNTrial Begins for Woman Accused of Killing Friend in Garden GroveA 55-year-old woman shot and killed her roommate in Garden Grove as she threatened to do and told her boyfriend she had to flee to Mexico, a prosecutor told jurors Thursday as the defendant’s attorney ...
3h
Zacks Investment Research on MSNRegeneron Stock Plunges 22.6% YTD: Should You Buy, Sell or Hold?Shares of Regeneron Pharmaceuticals, Inc. REGN have lost 22.6% year to date against the industry’s growth of 0.6%. The stock ...
Modality-Based Medicine in Anti-Tumor Immunity: Overcoming Resistance and Enhancing Immune Precision
The field of oncology has been revolutionized by the introduction of immune checkpoint inhibitors, with anti-PD-1 therapies offering durable responses in ...
Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results